Home » Medical

3,4 DAP / Firdapse®

Article posted on 21 May 2013 Leave a Comment

A number of CMS patients and families with children who use 3,4 DAP have been concerned over recent changes to both the supply and branding of this drug.

To download a factsheet issued by the Myasthenia Gravis Association on 30 July 2010, click here.

To view a report on the issue from the NHS North East Advisory Group, click here.

To read the Sunday Express story on this from 5th September 2010, click here.

Leave your response!

Add your comment below, or trackback from your own site. You can also subscribe to these comments via RSS.

Be nice. Keep it clean. Stay on topic. No spam.

This is a Gravatar-enabled blog. To get your own globally-recognized-avatar, please register at Gravatar.